Starbucks (SBUX)
(Delayed Data from NSDQ)
$98.57 USD
-0.71 (-0.72%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $98.62 +0.05 (0.05%) 5:28 PM ET
3-Hold of 5 3
D Value B Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$98.57 USD
-0.71 (-0.72%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $98.62 +0.05 (0.05%) 5:28 PM ET
3-Hold of 5 3
D Value B Growth F Momentum C VGM
Zacks News
Stock Market News for Feb 6, 2023
by Zacks Equity Research
Wall Street closed sharply lower on Friday, dragged down by mega-cap tech stocks.
Starbucks (SBUX) Q1 Earnings & Revenues Miss, Stock Dips
by Zacks Equity Research
Inflationary pressure, high spending on labor growth and sales deleverage due to COVID-19 restrictions in China affect Starbucks' (SBUX) fiscal first-quarter margins.
Starbucks (SBUX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Starbucks (SBUX) give insight into how the company performed in the quarter ended December 2022, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Cavalcade of Earnings: AAPL, AMZN, GOOGL & More
by Mark Vickery
Apple, Amazon and Alphabet all reported quarterly numbers today -- and that's just the A's.
Starbucks (SBUX) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Starbucks (SBUX) delivered earnings and revenue surprises of -2.60% and 1.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Starbucks (SBUX) This Earnings Season?
by Zacks Equity Research
Starbucks (SBUX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
5 Earnings Charts at 52-Week Highs
by Tracey Ryniec
Will 2023's winning stocks continue to rally?
Chipotle Mexican Grill (CMG) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Chipotle (CMG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How to Boost Your Portfolio with Top Retail and Wholesale Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Starbucks (SBUX) Gears Up for Q1 Earnings: What's in Store?
by Zacks Equity Research
Starbucks' (SBUX) first-quarter fiscal 2023 results are likely to reflect robust North America sales.
Starbucks (SBUX) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Starbucks (SBUX) closed at $108.76, marking a +1.66% move from the previous day.
Yum China's (YUMC) Sales Building Efforts Aid Amid Cost Woes
by Zacks Equity Research
Menu innovation, strong loyalty program and increased digitalization drive Yum China's (YUMC) growth.
Factors Setting the Tone for Brinker's (EAT) Q2 Earnings
by Zacks Equity Research
Brinker's (EAT) second-quarter fiscal 2023 top line is likely to reflect benefits from solid Chili's performance, sales-building initiatives and expansion efforts.
Starbucks (SBUX) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Starbucks (SBUX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Starbucks (SBUX) Benefits From Robust North America Comps
by Zacks Equity Research
Starbucks (SBUX) benefits from robust North America comps growth, expansion efforts and menu innovation.
McDonald's (MCD) to Post Q4 Earnings: What's in the Offing?
by Zacks Equity Research
McDonald's (MCD) fourth-quarter 2022 top line is likely to have negatively impacted by decline in international operated markets revenues.
Starbucks (SBUX) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Starbucks (SBUX) closed at $106.21 in the latest trading session, marking a +1.11% move from the prior day.
Beat the Market Like Zacks: Boeing, Starbucks, Syndax Pharma in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Will Starbucks (SBUX) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Starbucks (SBUX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Starbucks (SBUX) Expands U.S. Delivery With DoorDash Tie-up
by Zacks Equity Research
Starbucks (SBUX) and DoorDash anticipate nationwide store coverage in 50 states by March 2023.
Starbucks (SBUX) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Starbucks (SBUX) closed at $106.75, marking a -0.45% move from the previous day.
Starbucks (SBUX) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Starbucks (SBUX) closed at $106.30 in the latest trading session, marking a +0.28% move from the prior day.
The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Starbucks, Moderna, Canadian Pacific Railway and Micron Technology
by Zacks Equity Research
Thermo Fisher Scientific, Starbucks, Moderna, Canadian Pacific Railway and Micron Technology are included in this Analyst Blog.
Top Stock Reports for Thermo Fisher Scientific, Starbucks & Moderna
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc. (TMO), Starbucks Corporation (SBUX) and Moderna, Inc. (MRNA).
Starbucks (SBUX) Stock Rises 37% in 6 Months: More Room to Run?
by Zacks Equity Research
Starbucks (SBUX) benefits from solid global footprint, successful innovations and digital offerings.